Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 234

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies

Hillman, Alan L., Eisenberg, John M., Pauly, Mark V., Bloom, Bernard S., Click, Henry, Kinosian, Bruce, Schwartz, J. Sanford·1991·New England Journal of Medicine

Abstract

Because of the growing focus on containing health care costs, pharmaceutical companies are trying to demonstrate the cost effectiveness of their products relative to alternatives. In Europe and Australia, economic analyses are often required for government approval and pricing of new pharmaceuticals. In the United States, such analyses are increasingly being used for marketing and to obtain formulary approval. Because of the corporate need for timely results and confidentiality about a new drug in the period before marketing begins and because other financial support is limited, pharmaceutical companies themselves sponsor most academic research into the cost effectiveness of pharmaceuticals. The . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199105093241911

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Metadata

Authors
Hillman, A. L., Eisenberg, J. M., Pauly, M. V., Bloom, B. S., Click, H., Kinosian, B., & Schwartz, J. S.
Venue
New England Journal of Medicine
Published
1991-05-09
Volume
324
Issue
19
Pages
1362-1365
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2338601379
Cited by
234
References
2
FWCI
23.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies. https://app.cochat.ai/papers/10.1056/nejm199105093241911
The paper
Hillman, A. L., Eisenberg, J. M., Pauly, M. V., Bloom, B. S., Click, H., Kinosian, B., & Schwartz, J. S. (1991). Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies. New England Journal of Medicine. https://doi.org/10.1056/nejm199105093241911

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.